2) Phosphoryl peptide methyl ester
磷酰肽甲酯
4) peptide deformylase
肽脱甲酰化酶
1.
Current status of peptide deformylase and its inhibitors;
肽脱甲酰化酶及其抑制剂研究进展
2.
According to the structure-activity relationship of peptide deformylase inhibitors,a series of hydroxamic acid derivatives containing isoxazole were designed and synthesized based on the structure of actinonin.
通过对肽脱甲酰化酶抑制剂构效关系的研究,以放线酰胺素为先导化合物,设计并合成了一系列异噁唑类化合物。
5) peptide deformylase
肽脱甲酰基酶
1.
The advance of the peptide deformylase inhibitor LBM-415;
肽脱甲酰基酶抑制剂LBM-415的研究进展
2.
Progresses in the investigations of peptide deformylase inhibitors;
肽脱甲酰基酶抑制剂的构效关系研究进展
3.
Both the inhibitors of peptide deformylase and oxazolidinones are the foci on the research of novel totally-synthesized antibacterial agents which function by blocking the protein synthesis in bacterial cells.
肽脱甲酰基酶抑制剂和噁唑烷酮类抗菌剂是近年来新型全合成抗菌药的研究热点,它们都作用于细菌蛋白质的合成。
6) formylpeptide receptor
甲酰化肽受体
1.
Expression of functional formylpeptide receptor FPR by primary human malignant glioma cells;
在人恶性胶质瘤原代培养细胞甲酰化肽受体FPR的表达和功能意义
2.
Objective To observe the effects of Nordy,a synthetic compound,on the expression of formylpeptide receptor(FPR)and vascular endothelial growth factor(VEGF)in orthotopically implanted tumor in the brain of human malignant glioma-bearing nude mice and explore the mechanism of anti-tumor effect of Nordy.
目的观察诺帝对人恶性胶质瘤裸鼠原位移植瘤甲酰化肽受体(FPR)、血管内皮生长因子(VEGF)表达的影响,探讨其在抗胶质瘤血管生成的治疗意义。
3.
To investigate the effects of nordy(25-100 μmol·L~(-1)) on the function of formylpeptide receptor(FPR) of malignant human glioma cells,human glioblastoma cell line U87 was used to detect its proliferation,migration,calcium mobilization,vascular endothelial growth factor(VEGF) mRNA and protein levels after activation of FPR by its agonist N-formyl-methionyl-leucyl-phenylalanine(fMLF).
探讨手性化合物诺帝对人恶性胶质瘤细胞甲酰化肽受体(formylpeptide receptor,FPR)功能的影响及其意义。
补充资料:3-磺酰氨基乙酸甲酯-2-噻吩甲酸甲酯
分子式:C9H11NO6S2
分子量:293.32
CAS号:106820-63-7
性质:熔点96-98°C。
分子量:293.32
CAS号:106820-63-7
性质:熔点96-98°C。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条